» Articles » PMID: 16814107

Increased Oxidative Stress is Correlated with Mitochondrial Dysfunction in Chagasic Patients

Overview
Date 2006 Jul 4
PMID 16814107
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Previously, we have shown in an experimental model of Trypanosoma cruzi infection that increased oxidative stress and antioxidant insufficiency are associated with myocardial (cellular and mitochondrial) oxidative damage and mitochondrial functional decline and might be of pathological significance in Chagas disease. In the present study, we investigated whether enhanced oxidative stress and mitochondrial functional decline are found in human chagasic patients. Our data show substantially higher plasma (two-four-fold) and mitochondrial (67%) malonylaldehyde (MDA) levels in chagasic (n = 80, group 2) compared to healthy (n = 50, group 1) subjects. Moreover, antioxidant defense was compromised in chagasic patients. Hence, we noted a 50% decline in glutathione content and losses of 31, 60, and 68% in glutathione peroxidase, superoxide dismutase (SOD), and MnSOD activities, respectively, relative to the findings in healthy controls. Further, chagasic subjects exhibited decreased mitochondrial respiratory complex (CI: 72%; CIII: 71%) activities. Nonchagasic cardiomyopathy subjects (n = 20, group 3) exhibited marginally higher plasma MDA levels compared to gp1 subjects and were not compromised in plasma antioxidant defense capacity. These data suggest that human chagasic patients sustain an antioxidant/oxidant imbalance and a mitochondrial decline of respiratory complex activities in the circulatory system. A positive correlation between increased MDA levels, MnSOD decline, and inhibition of respiratory complexes suggests that oxidative stress may contribute to mitochondrial dysfunction in chagasic patients.

Citing Articles

Secretome profiling reveals acute changes in oxidative stress, brain homeostasis, and coagulation following short-duration spaceflight.

Houerbi N, Kim J, Overbey E, Batra R, Schweickart A, Patras L Nat Commun. 2024; 15(1):4862.

PMID: 38862464 PMC: 11166969. DOI: 10.1038/s41467-024-48841-w.


Arrhythmogenic Manifestations of Chagas Disease: Perspectives From the Bench to Bedside.

Roman-Campos D, Marin-Neto J, Santos-Miranda A, Kong N, dAvila A, Rassi Jr A Circ Res. 2024; 134(10):1379-1397.

PMID: 38723031 PMC: 11081486. DOI: 10.1161/CIRCRESAHA.124.324507.


Differential cardiomyocyte transcriptomic remodeling during in vitro Trypanosoma cruzi infection using laboratory strains provides implications on pathogenic host responses.

Candray-Medina K, Nakagama Y, Ito M, Nakagama S, Tshibangu-Kabamba E, Takeda N Trop Med Health. 2023; 51(1):68.

PMID: 38062533 PMC: 10702087. DOI: 10.1186/s41182-023-00552-6.


Platelets, Macrophages, and Thromboinflammation in Chagas Disease.

Choudhuri S, Garg N J Inflamm Res. 2022; 15:5689-5706.

PMID: 36217453 PMC: 9547606. DOI: 10.2147/JIR.S380896.


Selenium, TGF-Beta and Infectious Endemic Cardiopathy: Lessons from Benchwork to Clinical Application in Chagas Disease.

Araujo-Jorge T, Rivera M, Vanderpas J, Garzoni L, Carvalho A, Waghabi M Biomolecules. 2022; 12(3).

PMID: 35327541 PMC: 8944995. DOI: 10.3390/biom12030349.